Literature DB >> 17049490

The HBSP gene is expressed during HBV replication, and its coded BH3-containing spliced viral protein induces apoptosis in HepG2 cells.

Yi Wei Lu1, Tuan Lin Tan, Vincent Chan, Wei Ning Chen.   

Abstract

The mechanisms of liver injury in hepatitis B virus (HBV) infection are defined to be due not to the direct cytopathic effects of viruses, but to the host immune response to viral proteins expressed by infected hepatocytes. We showed here that transfection of mammalian cells with a replicative HBV genome causes extensive cytopathic effects, leading to the death of infected cells. While either necrosis or apoptosis or both may contribute to the death of infected cells, results from flow cytometry suggest that apoptosis plays a major role in HBV-induced cell death. Data mining of the four HBV protein sequences reveals the presence of a Bcl-2 homology domain 3 (BH3) in HBSP, a spliced viral protein previously shown to be able to induce apoptosis and associated with HBV pathogenesis. HBSP is expressed at early stage of our cell-based HBV replication. When transfected into HepG2 cells, HBSP causes apoptosis in a caspase dependent manner. Taken together, our results suggested a direct involvement of HBV viral proteins in cellular apoptosis, which may contribute to liver pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049490     DOI: 10.1016/j.bbrc.2006.10.002

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  The hepatitis C virus core protein contains a BH3 domain that regulates apoptosis through specific interaction with human Mcl-1.

Authors:  Nur Khairiah Mohd-Ismail; Lin Deng; Sunil Kumar Sukumaran; Victor C Yu; Hak Hotta; Yee-Joo Tan
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 2.  Molecular characteristics and stages of chronic hepatitis B virus infection.

Authors:  Ying-Hui Shi; Chang-He Shi
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

3.  Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.

Authors:  Scott Preiss; Margaret Littlejohn; Peter Angus; Alex Thompson; Paul Desmond; Sharon R Lewin; Joe Sasadeusz; Gail Matthews; Gregory J Dore; Tim Shaw; Vitini Sozzi; Lilly Yuen; George Lau; Anna Ayres; Chloe Thio; Anchalee Avihingsanon; Kiat Ruxrungtham; Stephen Locarnini; Peter A Revill
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

4.  Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling.

Authors:  Shu-Xiang Wu; Wan-Nan Chen; Zhen-Tang Jing; Wei Liu; Xin-Jian Lin; Xu Lin
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 5.  Role of apoptosis in disease.

Authors:  Bartolo Favaloro; Nerino Allocati; Vincenzo Graziano; Carmine Di Ilio; Vincenzo De Laurenzi
Journal:  Aging (Albany NY)       Date:  2012-05       Impact factor: 5.682

6.  The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation.

Authors:  Yi-Ling Wang; Gan-Guang Liou; Chao-Hsiung Lin; Mong-Liang Chen; Tzer-Min Kuo; Kuen-Nan Tsai; Chien-Choao Huang; Ya-Ling Chen; Li-Rung Huang; Yu-Chi Chou; Chungming Chang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 7.  Interference of Apoptosis by Hepatitis B Virus.

Authors:  Shaoli Lin; Yan-Jin Zhang
Journal:  Viruses       Date:  2017-08-18       Impact factor: 5.048

8.  Effects of hepatitis B virus mutations on its replication and liver disease severity.

Authors:  Abdulrahim Hakami; Abdelwahid Ali; Ahmed Hakami
Journal:  Open Virol J       Date:  2013-01-23

9.  Cellular apoptosis induced by replication of hepatitis B virus: possible link between viral genotype and clinical outcome.

Authors:  Yi Wei Lu; Tuan Lin Tan; Jianhua Zhang; Wei Ning Chen
Journal:  Virol J       Date:  2007-10-31       Impact factor: 4.099

10.  Hepatitis B splice-generated protein antibodies in Syrian chronic hepatitis B patients: incidence and significance.

Authors:  Nour Al-Hanafi; Fawza Monem
Journal:  Hepat Mon       Date:  2014-04-16       Impact factor: 0.660

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.